Wuxi AppTec
Foreign stocks · Drug research services
Investors in Thailand can buy 603259.SS through 24 mutual funds open to retail investors. Most of them (24 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds 603259.SS.
| Fund | 603259.SS weight | How it invests | 1-year return |
|---|---|---|---|
 UCHIUnited China Healthcare Innovation Fund | 8.42% | Via several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | −5.02% |
 |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
| Master fund | Thai funds using this route | Master fund's 603259.SS weight |
|---|---|---|
| Schroder International Selection Fund China A | 4 | 2.82% |
| Goldman Sachs China A-Share Equity Portfolio | 3 | 3.18% |
| UBS (Lux) IS - China A Opportunity | 2 | 6.27% |
| BGF China Fund | 2 | 3.54% |
| Allianz China A-Shares |
| 6.27% |
| Via UBS (Lux) IS - China A Opportunity |
| −14.14% |
| ES-CHINAA-AEastspring China A Active Fund | 6.25% | Via UBS (Lux) IS - China A Opportunity | −13.46% |
 TCHSTRATEGYTISCO China Strategy Fund | 4.07% | Via several master funds | +3.09% |
 KT-CHINA-AKTAM China Equity Fund | 3.54% | Via BGF China Fund | −16.51% |
| KT-CHINA RMFKTAM China Equity RMF | 3.53% | Via BGF China Fund | −16.56% |
 MCHINAGAMFC China Equity Fund | 3.47% | Via Allianz China A-Shares | −0.58% |
 B-CHINAARMFBualuang China A-Shares Equity RMF | 3.39% | Via Allianz China A-Shares | +3.43% |
| GCGreater China Fund | 3.36% | Via Goldman Sachs Greater China Equity | −7.36% |
 SCBCHEQASCB All China Equity Fund | 3.32% | Via Schroder International Selection Fund All China Equity | −13.92% |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 142.36 | 143.50 | Above |
| 20 days | 147.65 | 146.86 | Above |
| 50 days | 154.74 | 148.62 | Below |
| 100 days | 140.41 | 140.76 | Above |
| 200 days |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 50.47 | Up |
| MACD(12,26) | −4.03 | Down |
| ADX(14) | 30.87 | Neutral |
| ATR(14) % of price | 2.31 | Neutral |
No financial statements for 603259.SS in the system yet — the share price above is the actual daily close
KTAM4SCBAM3
PRINCIPAL3
KSAM3UOBAM2BBLAM2TISCOASSET1| Fund | 603259.SS weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| UCHI | 8.42% | several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | −5.02% | 1.86% |
| ES-CHINAARMF | 6.27% | UBS (Lux) IS - China A Opportunity | −14.14% | 1.77% |
| ES-CHINAA-A | 6.25% | UBS (Lux) IS - China A Opportunity | −13.46% | 1.03% |
| TCHSTRATEGY | 4.07% | several master funds | +3.09% | 1.73% |
| KT-CHINA-A | 3.54% | BGF China Fund | −16.51% | 1.54% |
| KT-CHINA RMF | 3.53% | BGF China Fund | −16.56% | 1.33% |
| MCHINAGA | 3.47% | Allianz China A-Shares | −0.58% | 1.76% |
| B-CHINAARMF | 3.39% | Allianz China A-Shares | +3.43% | 1.19% |
| GC | 3.36% | Goldman Sachs Greater China Equity | −7.36% | 2.45% |
| SCBCHEQA | 3.32% | Schroder International Selection Fund All China Equity | −13.92% | 1.71% |
| PRINCIPAL CHEQ-A | 3.32% | Schroder International Selection Fund All China Equity | −14.29% | 1.98% |
 DAOL-CHINABIO | 3.20% | 3069 | N/A | 1.96% |
| KF-ACHINA-A | 3.18% | Goldman Sachs China A-Share Equity Portfolio | −18.46% | 1.53% |
| KF-ACHINARMF | 3.17% | Goldman Sachs China A-Share Equity Portfolio | −18.78% | 1.54% |
| KF-ACHINASSF | 3.16% | Goldman Sachs China A-Share Equity Portfolio | −18.58% | 1.55% |
| SCBASHARE(SSFE) | 2.82% | Schroder International Selection Fund China A | +5.69% | 0.10% |
| SCBRMASHARES(A) | 2.81% | Schroder International Selection Fund China A | +4.50% | 1.19% |
| KT-Ashares RMF | 2.79% | Schroder International Selection Fund China A | +3.56% | 1.33% |
| KT-Ashares-A | 2.78% | Schroder International Selection Fund China A | +3.65% | 1.53% |
| PRINCIPAL APDIRMF | 2.29% | Principal Asia Pacific Dynamic Income Fund | +4.56% | 2.19% |
| Fund | 603259.SS weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| PRINCIPAL APDI-A | 2.27% | Principal Asia Pacific Dynamic Income Fund | +4.64% | 1.96% |
| ES-ASIARMF | 2.08% | Schroder International Selection Fund - Emerging Asia | +10.26% | 1.84% |
| ES-ASIA-A | 2.08% | Schroder International Selection Fund - Emerging Asia | +9.70% | 1.77% |
| B-CNA500P | 1.44% | 512050 | −0.12% | 0.73% |
| 2 |
| 3.47% |
| Schroder International Selection Fund All China Equity | 2 | 3.32% |
| Principal Asia Pacific Dynamic Income Fund | 2 | 2.29% |
| Schroder International Selection Fund - Emerging Asia | 2 | 2.08% |
| several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | 1 | 8.42% |
| several master funds | 1 | 4.07% |
| Goldman Sachs Greater China Equity | 1 | 3.36% |
| Hang Seng Biotech Index ETF | 1 | 3.20% |
| ChinaAMC CSI A500 Exchange Traded Fund | 1 | 1.44% |
| 120.06 |
| 126.06 |
| Above |
